Goodman Noah Insider Trades

Insider Trading History

Track insider trading activity for Goodman Noah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.29M 47,179 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$387k 3,389 shares
$114.29
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.91M 52,695 shares
Last Trade
Jun 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$570k 5,000 shares
$114.00
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $6.19M 55,195 shares
Last Trade
Jun 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$582k 5,000 shares
$116.46
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $10.1M 90,000 shares
Last Trade
Jun 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$582k 5,000 shares
$116.46
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $10.6M 95,000 shares
Last Trade
Jun 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$249k 2,500 shares
$99.45
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.63M 50,195 shares
Last Trade
Jun 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$248k 2,500 shares
$99.00
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.91M 52,695 shares
Last Trade
Jun 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$249k 2,500 shares
$99.45
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.63M 50,195 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$121k 1,347 shares
$90.00
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $5.78M 51,542 shares
Last Trade
Apr 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$175k 2,000 shares
$87.35
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $6.58M 58,712 shares
Last Trade
Apr 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$723k 8,264 shares
$87.50
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $6.93M 61,806 shares
Last Trade
Apr 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$218k 2,500 shares
$87.35
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $10.9M 97,500 shares
Last Trade
Apr 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$218k 2,500 shares
$87.35
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $6.65M 59,306 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.49M 27,675 shares
$90.10
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Business Officer
Holding Value $11.2M 100,000 shares
Last Trade
Apr 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.11M 100,000 shares
$21.05
$112.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up